Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 12,680 shares at $52.00 ($655K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Scheduled sale ($655k) by EVP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.00 | 10,773 | $560K | 85.6% |
| 2 | $49.56 | 1,907 | $95K | 14.4% |
| Total | $51.63 avg | 12,680 | $655K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |